{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,29]],"date-time":"2025-08-29T10:34:54Z","timestamp":1756463694308},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T00:00:00Z","timestamp":1419897600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["CEN Case Rep"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1007\/s13730-014-0165-7","type":"journal-article","created":{"date-parts":[[2014,12,29]],"date-time":"2014-12-29T11:53:22Z","timestamp":1419854002000},"page":"190-195","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Successful treatment by mycophenolate mofetil in a patient with focal segmental glomerulosclerosis associated with posterior reversible encephalopathy syndrome"],"prefix":"10.1007","volume":"4","author":[{"given":"Masafumi","family":"Tenta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haruhito Adam","family":"Uchida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomokazu","family":"Nunoue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryoko","family":"Umebayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuka","family":"Okuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Kitagawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yohei","family":"Maeshima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Wada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,12,30]]},"reference":[{"key":"165_CR1","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1136\/pmj.77.903.24","volume":"77","author":"RK Garg","year":"2001","unstructured":"Garg RK. Posterior leukoencephalopathy syndrome. Postgrad Med J. 2001;77:24\u20138.","journal-title":"Postgrad Med J"},{"key":"165_CR2","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1056\/NEJM199602223340803","volume":"334","author":"J Hinchey","year":"1996","unstructured":"Hinchey J, Chaves C, Appignani B, Breen J, Pao L, Wang A, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med. 1996;334:494\u2013500.","journal-title":"N Engl J Med"},{"key":"165_CR3","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1055\/s-0031-1277990","volume":"31","author":"SK Feske","year":"2011","unstructured":"Feske SK. Posterior reversible encephalopathy syndrome: a review. Semin Neurol. 2011;31:202\u201315.","journal-title":"Semin Neurol"},{"key":"165_CR4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.5414\/CNP73482","volume":"73","author":"N Sakai","year":"2010","unstructured":"Sakai N, Kawasaki Y, Imaizumi T, Kanno S, Go H, Mitomo M, et al. Two patients with focal segmental glomerulosclerosis complicated by cyclosporine-induced reversible posterior leukoencephalopathy syndrome. Clin Nephrol. 2010;73:482\u20136.","journal-title":"Clin Nephrol"},{"key":"165_CR5","first-page":"439","volume":"19","author":"B Saeed","year":"2008","unstructured":"Saeed B, Abou-Zor N, Amer Z, Kanani I, Hilal M. Cyclosporin-A induced posterior reversible encephalopathy syndrome. Saudi J Kidney Dis Transpl. 2008;19:439\u201342.","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"165_CR6","doi-asserted-by":"crossref","first-page":"587","DOI":"10.3747\/pdi.2011.00055","volume":"32","author":"A Ogawa","year":"2012","unstructured":"Ogawa A, Sugiyama H, Nakayama K, Morinaga H, Akagi S, Makino H. Reversible posterior leukoencephalopathy syndrome in a young adult patient receiving peritoneal dialysis. Perit Dial Int. 2012;32:587\u20139.","journal-title":"Perit Dial Int"},{"key":"165_CR7","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1093\/ndt\/gfn013","volume":"23","author":"K Ishikura","year":"2008","unstructured":"Ishikura K, Ikeda M, Hamasaki Y, Hataya H, Nishimura G, Hiramoto R, et al. Nephrotic state as a risk factor for developing posterior reversible encephalopathy syndrome in paediatric patients with nephrotic syndrome. Nephrol Dial Transpl. 2008;23:2531\u20136.","journal-title":"Nephrol Dial Transpl"},{"key":"165_CR8","doi-asserted-by":"crossref","first-page":"E30","DOI":"10.1016\/S0272-6386(01)90016-2","volume":"37","author":"M Ikeda","year":"2001","unstructured":"Ikeda M, Ito S, Hataya H, Honda M, Anbo K. Reversible posterior leukoencephalopathy in a patient with minimal-change nephrotic syndrome. Am J Kidney Dis. 2001;37:E30.","journal-title":"Am J Kidney Dis"},{"key":"165_CR9","first-page":"U2257","volume":"119","author":"J Li Looi","year":"2006","unstructured":"Li Looi J, Christiansen JP. Reversible posterior leukoencephalopathy associated with minimal change nephrotic syndrome. N Z Med J. 2006;119:U2257.","journal-title":"N Z Med J"},{"key":"165_CR10","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000045931","volume":"87","author":"BS Kim","year":"2001","unstructured":"Kim BS, Lee SH, Lee JE, Chung SW, Kim YO, Choi KB, et al. Posterior leukoencephalopathy syndrome during steroid therapy in a down syndrome patient with nephrotic syndrome. Nephron. 2001;87:289\u201390.","journal-title":"Nephron"},{"issue":"Suppl 1","key":"165_CR11","first-page":"S8","volume":"35","author":"J Brodehl","year":"1991","unstructured":"Brodehl J. Conventional therapy for idiopathic nephrotic syndrome in children. Clin Nephrol. 1991;35(Suppl 1):S8\u201315.","journal-title":"Clin Nephrol"},{"key":"165_CR12","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0272-6386(12)80353-2","volume":"17","author":"S Fujimoto","year":"1991","unstructured":"Fujimoto S, Yamamoto Y, Hisanaga S, Morita S, Eto T, Tanaka K. Minimal change nephrotic syndrome in adults: response to corticosteroid therapy and frequency of relapse. Am J Kidney Dis. 1991;17:687\u201392.","journal-title":"Am J Kidney Dis"},{"key":"165_CR13","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1053\/ajkd.2002.31400","volume":"39","author":"M Nakayama","year":"2002","unstructured":"Nakayama M, Katafuchi R, Yanase T, Ikeda K, Tanaka H, Fujimi S. Steroid responsiveness and frequency of relapse in adult-onset minimal change nephrotic syndrome. Am J Kidney Dis. 2002;39:503\u201312.","journal-title":"Am J Kidney Dis"},{"key":"165_CR14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.5858\/133.2.201","volume":"133","author":"L Barisoni","year":"2009","unstructured":"Barisoni L, Schnaper HW, Kopp JB. Advances in the biology and genetics of the podocytopathies: implications for diagnosis and therapy. Arch Pathol Lab Med. 2009;133:201\u201316.","journal-title":"Arch Pathol Lab Med"},{"key":"165_CR15","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1038\/nm.2411","volume":"17","author":"C Wei","year":"2011","unstructured":"Wei C, El Hindi S, Li J, Fornoni A, Goes N, Sageshima J, et al. Circulating urokinase receptor as a cause of focal segmental glomerulosclerosis. Nat Med. 2011;17:952\u201360.","journal-title":"Nat Med"},{"key":"165_CR16","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/ki.2013.544","volume":"85","author":"T Wada","year":"2014","unstructured":"Wada T, Nangaku M, Maruyama S, Imai E, Shoji K, Kato S, et al. A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular disease. Kidney Int. 2014;85:641\u20138.","journal-title":"Kidney Int"},{"key":"165_CR17","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/ki.2013.546","volume":"85","author":"A Sinha","year":"2014","unstructured":"Sinha A, Bajpai J, Saini S, Bhatia D, Gupta A, Puraswani M, et al. Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children. Kidney Int. 2014;85:649\u201358.","journal-title":"Kidney Int"},{"key":"165_CR18","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1053\/j.ackd.2011.03.005","volume":"18","author":"J Kiffel","year":"2011","unstructured":"Kiffel J, Rahimzada Y, Trachtman H. Focal segmental glomerulosclerosis and chronic kidney disease in pediatric patients. Adv Chronic Kidney Dis. 2011;18:332\u20138.","journal-title":"Adv Chronic Kidney Dis"},{"key":"165_CR19","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00540-008-0726-z","volume":"23","author":"J Oto","year":"2009","unstructured":"Oto J, Suga K, Matsuura S, Kondo S, Ohnishi Y, Inui D, et al. Low-density lipoprotein apheresis in a pediatric patient with refractory nephrotic syndrome due to focal segmental glomerulosclerosis. J Anesth. 2009;23:284\u20137.","journal-title":"J Anesth"},{"key":"165_CR20","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/j.cellsig.2013.05.008","volume":"25","author":"R Eguchi","year":"2013","unstructured":"Eguchi R, Kubo S, Ohta T, Kunimasa K, Okada M, Tamaki H, et al. FK506 induces endothelial dysfunction through attenuation of Akt and ERK1\/2 independently of calcineurin inhibition and the caspase pathway. Cell Signal. 2013;25:1731\u20138.","journal-title":"Cell Signal"},{"key":"165_CR21","doi-asserted-by":"crossref","first-page":"203","DOI":"10.5301\/JN.2011.6327","volume":"24","author":"TT Gargah","year":"2011","unstructured":"Gargah TT, Lakhoua MR. Mycophenolate mofetil in treatment of childhood steroid-resistant nephrotic syndrome. J Nephrol. 2011;24:203\u20137.","journal-title":"J Nephrol"},{"key":"165_CR22","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1093\/ndt\/gfr572","volume":"27","author":"J Gellermann","year":"2012","unstructured":"Gellermann J, Ehrich JH, Querfeld U. Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Nephrol Dial Transpl. 2012;27:1970\u20138.","journal-title":"Nephrol Dial Transpl"},{"key":"165_CR23","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1093\/ndt\/gfm538","volume":"23","author":"L Senthil Nayagam","year":"2008","unstructured":"Senthil Nayagam L, Ganguli A, Rathi M, Kohli HS, Gupta KL, Joshi K, et al. Mycophenolate mofetil or standard therapy for membranous nephropathy and focal segmental glomerulosclerosis: a pilot study. Nephrol Dial Transpl. 2008;23:1926\u201330.","journal-title":"Nephrol Dial Transpl"},{"key":"165_CR24","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1093\/ndt\/gfs563","volume":"28","author":"PA Canetta","year":"2013","unstructured":"Canetta PA, Radhakrishnan J. Impact of the National Institutes of Health Focal Segmental Glomerulosclerosis (NIH FSGS) clinical trial on the treatment of steroid-resistant FSGS. Nephrol Dial Transpl. 2013;28:527\u201334.","journal-title":"Nephrol Dial Transpl"},{"key":"165_CR25","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s00795-003-0213-4","volume":"36","author":"H Masuda","year":"2003","unstructured":"Masuda H, Fujihira S, Ueno H, Kagawa M, Katsuoka Y, Mori H. Ultrastructural study on cytotoxic effects of cyclosporine A in spermiogenesis in rats. Med Electron Microsc. 2003;36:183\u201391.","journal-title":"Med Electron Microsc"},{"key":"165_CR26","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1093\/ndt\/gfm780","volume":"23","author":"W Hu","year":"2008","unstructured":"Hu W, Liu C, Xie H, Chen H, Liu Z, Li L. Mycophenolate mofetil versus cyclophosphamide for inducing remission of ANCA vasculitis with moderate renal involvement. Nephrol Dial Transpl. 2008;23:1307\u201312.","journal-title":"Nephrol Dial Transpl"},{"key":"165_CR27","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.intimp.2005.01.015","volume":"5","author":"Y Huang","year":"2005","unstructured":"Huang Y, Liu Z, Huang H, Liu H, Li L. Effects of mycophenolic acid on endothelial cells. Int Immunopharmacol. 2005;5:1029\u201339.","journal-title":"Int Immunopharmacol"}],"container-title":["CEN Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0165-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13730-014-0165-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13730-014-0165-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T14:41:43Z","timestamp":1650897703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13730-014-0165-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,30]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["165"],"URL":"https:\/\/doi.org\/10.1007\/s13730-014-0165-7","relation":{},"ISSN":["2192-4449"],"issn-type":[{"value":"2192-4449","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,30]]}}}